SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: Robert Voigt who wrote (517)1/28/1998 4:58:00 PM
From: PawPr  Read Replies (2) | Respond to of 965
 
The competing drug by CORR was recommended for approval with reservations by the advisory panel. Most in the medical community suspected that CNTO's drug was superior and this seemed to confirm it. However, I doubt if CNTO will hold on to the big gain tomorrow.